Pulmonary Homograft from DCD patient for RVOT Reconstruction

Novel applications of pulmonary homografts in RVOT reconstruction have expanded their role beyond traditional conduit replacement, offering improved adaptability in complex reoperative settings. Contemporary techniques increasingly utilize tailored or “hybrid” pulmonary homografts - such as oversized, reinforced, or valveless configurations - to accommodate abnormal anatomic geometries, minimize suture-line tension, and enhance hemodynamic performance in patients with multiple prior sternotomies. The biologic compliance of homograft tissue allows for more physiologic RVOT contouring compared with synthetic materials, reducing turbulence and preserving native right ventricular function. Additionally, emerging tissue-engineering strategies, including decellularized or recellularizable homografts, show promise in promoting host integration and lowering long-term calcification rates. These innovations collectively highlight the evolving versatility of pulmonary homografts as a preferred substrate for complex RVOT reconstruction, particularly in redo congenital heart operations.